What AbbVie (ABBV)'s Restructured OSE Immunology Partnership Means For Shareholders [Yahoo! Finance]
AbbVie Inc. (ABBV)
Last abbvie inc. earnings: 5/1 07:43 am
Check Earnings Report
US:NYSE Investor Relations:
investors.abbvie.com/investor-overview
Company Research
Source: Yahoo! Finance
taking back control of preclinical and Phase 1 work, at its own funding risk, while AbbVie kept exclusive rights to later-stage development and commercialization on unchanged economic terms. The revised ABBV-230 arrangement underlines AbbVie's willingness to lean on partners' early-stage immunology expertise while reserving control of potential first-in-class inflammation therapies once early safety is proven. We'll now examine how AbbVie's choice to let OSE fund early ABBV-230 work while preserving downstream rights influences its investment narrative. We've found 11 US stocks that are forecast to pay a dividend yield of over 6% next year . See the full list for free. To own AbbVie, you need to believe that Skyrizi, Rinvoq and the broader pipeline can more than offset Humira's erosion while supporting the dividend and debt load. The ABBV-230 amendment with OSE does not materially change the key near term catalyst, which still centers on immunology growth and policy decisions
Show less
Read more
Impact Snapshot
Event Time:
ABBV
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ABBV alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ABBV alerts
High impacting AbbVie Inc. news events
Weekly update
A roundup of the hottest topics
ABBV
News
- ????????????????????????????2035????128???????????? [CNET News]CNET News
- Vanguard Health Care Fund's Strategic Moves: Spotlight on AbbVie Inc [Yahoo! Finance]Yahoo! Finance
- Is AbbVie a Millionaire Maker? [Yahoo! Finance]Yahoo! Finance
- Should You Invest in the State Street Health Care Select Sector SPDR ETF ETF (XLV)? [Yahoo! Finance]Yahoo! Finance
- AbbVie Ranked #15 in the Inaugural Fortune 100 Best Companies to Work For Southeast Asia 2025 ListPR Newswire
ABBV
Earnings
- 10/31/25 - Beat
ABBV
Sec Filings
- 11/20/25 - Form F-6
- 11/4/25 - Form 10-Q
- 10/31/25 - Form 8-K
- ABBV's page on the SEC website